Medicare to cover routine care costs in clinical trials
Arnold, K.; Vastag, B.
Journal of the National Cancer Institute 92(13): 1032
2000
ISSN/ISBN: 0027-8874 PMID: 10880539 Document Number: 522658
Document emailed within 1 workday
Related Documents
Baldwin, M. 1986: Bowen proposes Medicare expansion to cover costs of catastrophic illness Modern Healthcare 16(25): 8Schoenfeldt, M.; Trimble, E.L.; Denicoff, A.M.; O'Mara, A. 2003: Clinical trials referral resource. Current clinical trials of supportive care/palliative care Oncology 17(11): 1578; 1583-1585; 1589-1590
Mark, D.H.; Gottlieb, M.S.; Zellner, B.B.; Chetty, V.K.; Midtling, J.E. 1996: Medicare costs in urban areas and the supply of primary care physicians Journal of Family Practice 43(1): 33-39
Wagner, L. 1991: Medicare managed-care proposal faces skepticism it can cut costs, lure consumers Modern Healthcare 21(28): 32-33
Safran, D.Gelb.; Wilson, I.B.; Rogers, W.H.; Montgomery, J.E.; Chang, H. 2002: Primary care quality in the Medicare Program: comparing the performance of Medicare health maintenance organizations and traditional fee-for-service medicare Archives of Internal Medicine 162(7): 757-765
Reynolds, T. 2000: Costs studies show clinical trials, standard therapy may be equal Journal of the National Cancer Institute 92(14): 1116-1118
Scott, C.A.; Iyer, H.S.; Lembela Bwalya, D.; Bweupe, M.; Rosen, S.B.; Scott, N.; Larson, B.A. 2013: Uptake, outcomes, and costs of antenatal, well-baby, and prevention of mother-to-child transmission of HIV services under routine care conditions in Zambia Plos one 8(8): E72444
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Castrejón, I.; Tani, C.; Jolly, M.; Huang, A.; Mosca, M. 2014: Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care Clinical and Experimental Rheumatology 32(5 Suppl 85: S
Jones, F.H.; Leone, P.R.; Namenson, S.L. 1996: Reporting IDS home office costs for Medicare reimbursement Healthcare Financial Management: Journal of the Healthcare Financial Management Association 50(1): 36-38
Cook, A.E. 1999: Strategies for containing drug costs: implications for a Medicare benefit Health Care Financing Review 20(3): 29-37
Jenks, S. 1988: Rising hospital Medicare costs defy DRG control Medical World News 29(6): 50
Friesen, S. 2007: The Medicare trigger: what rising program costs could mean for surgery Bulletin of the American College of Surgeons 92(10): 15-21
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
2006: Out-of-pocket prescription costs a continuing burden under Medicare Part D American Family Physician 73(3): 402
Geekie, D.A. 1976: Physicians are not such high earners that they are producing runaway medicare costs Canadian Medical Association Journal 114(12): 1133
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323